Combined effect of donor and recipient risk on outcome after liver transplantation: Research of the Eurotransplant database

Liver Transplantation

Volumn 21, Issue 12, 2015, Pages 1486-1493

  Blok, Joris J ^a   Putter, Hein ^a   Rogiers, Xavier ^b   van Hoek, Bart ^a   Samuel, Undine ^c   Ringers, Jan ^a   Braat, Andries E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c EUROTRANSPLANT INTERNATIONAL FOUNDATION   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CHILD; COHORT ANALYSIS; DONOR; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEPATITIS B; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; SURVIVAL ANALYSIS;

EID: 84977620133     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.24308     Document Type: Article

References (23)

1. Braat AE, Blok JJ, Putter H, Adam R, Burroughs AK, Rahmel AO, et al.; for European Liver and Intestine Transplant Association (ELITA) and Eurotransplant Liver Intestine Advisory Committee (ELIAC). The Eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transplant 2012;12:2789–2796.
2. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006;6:783–790.
3. Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 2008;8:419–425.
4. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464–470.
5. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant 2005;5:307–313.
6. Rana A, Hardy MA, Halazun KJ, Woodland DC, Ratner LE, Samstein B, et al. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant 2008;8:2537–2546.
7. Halldorson JB, Bakthavatsalam R, Fix O, Reyes JD, Perkins JD. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant 2009;9:318–326.
8. Dutkowski P, Oberkofler CE, Slankamenac K, Puhan MA, Schadde E, Müllhaupt B, et al. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the Model for End-Stage Liver Disease era. Ann Surg 2011;254:745–753.
9. Braat AE, Blok JJ, Rahmel AO, Adam R, Burroughs AK, Putter H, et al. Incorporation of donor risk into liver allocation algorithms. Am J Transplant 2013;13:524–525.
10. Mataya L, Aronsohn A, Thistlethwaite JR Jr, Friedman Ross L. Decision making in liver transplantation--limited application of the liver donor risk index. Liver Transpl 2014;20:831–837.
11. Axelrod DA, Sung RS, Meyer KH, Wolfe RA, Kaufman DB. Systematic evaluation of pancreas allograft quality, outcomes and geographic variation in utilization. Am J Transplant 2010;10:837–845.
12. Rao PS, Schaubel DE, Guidinger MK, Andreoni KA, Wolfe RA, Merion RM, et al. A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation 2009;88:231–236.
13. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879–1886.
14. Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 2001;93:358–366.
15. Klein KB, Stafinski TD, Menon D. Predicting survival after liver transplantation based on pre-transplant MELD score: a systematic review of the literature. PLoS One 2013;8:e80661.
16. Biggins SW, Gralla J, Dodge JL, Bambha KM, Tong S, Barón AE, et al. Survival benefit of repeat liver transplantation in the United States: a serial MELD analysis by hepatitis C status and donor risk index. Am J Transplant 2014;14:2588–2594.
17. Eurotransplant Foundation. Chapter 5. ET liver allocation system (ELAS). In: Eurotransplant Manual, version 4.0. Leiden, the Netherlands: Eurotransplant Foundation; 2013:1–98.
18. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439–445.
19. Bernuau J, Goudeau A, Poynard T, Dubois F, Lesage G, Yvonnet B, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 1986;6:648–651.
20. Schaubel DE, Guidinger MK, Biggins SW, Kalbfleisch JD, Pomfret EA, Sharma P, Merion RM. Survival benefit-based deceased-donor liver allocation. Am. J. Transplant 2009;9(pt 2):970–981.
21. United Network for Organ Sharing. Organ Procurement and Transplantation (OPTN) Policies 2015. http://optn.transplant.hrsa.gov/contentdocuments/optn_policies.pdf. Accessed October 1, 2015.
22. Blok JJ, Braat AE, Adam R, Burroughs AK, Putter H, Kooreman NG, et al.; for European Liver Intestine Transplant Association Eurotransplant Liver Intestine Advisory Committee, Eurotransplant Liver Intestine Advisory Committee. Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region. Liver Transpl 2012;18:112–119.
23. Keller EJ, Kwo PY, Helft PR. Ethical considerations surrounding survival benefit-based liver allocation. Liver Transpl 2014;20:140–146.